Haleon PLC
Suletud
SektorTervishoid
362.9 0.42
Ülevaade
Aktsiahinna muutus
24h
Min
361.9
Max
363
Aktsiakasum | 0.044 |
|---|
Soovitused | Osta |
|---|---|
12 kuu keskmine prognoos | +12.54% upside |
Järgmine tulemuste avaldamine | 30. juuli 2026 |
|---|---|
Järgmine dividendimakse kuupäev | 17. sept 2026 |
Järgmine aktsia dividendi kuupäev (ex-date) | 13. aug 2026 |
Haleon PLC Graafik
Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.
Seotud uudised
Võrdlus sarnastega
Hinnamuutus
Haleon PLC Prognoos
Hinnasiht
By TipRanks
12.54% tõus
12 kuu keskmine prognoos
Keskmine 410 GBX 12.54%
Kõrge 512 GBX
Madal 315 GBX
Põhineb 12 Wall Streeti analüütiku instrumendi Haleon PLC 12 kuu hinnasihil - viimase 3 kuu andmed.
Finantsandmed
Müügi- ja halduskulud
Tegevuskulud
Maksueelne kasum
Müük
Müügikulu
Brutokasum müügist
Intressikulud võla pealt
EBITDA
Ärikasum
$
Ettevõttest Haleon PLC
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.